CXCL12 and neoplasm: The binding of CXCL12 (stromal cell-derived factor 1) to CXCR4 on tumor cells enhances proliferation, either via MAPK or PI3K/Akt pathways, and CXCL12 also recruits immunosuppressive cells as Tregs and MDSC that contribute to immune evasion [129].